Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value: $1.319B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | Insmed Inc | 1,600,000 | $117M | 8.9% | $51.36 | +43.7% | COM PAR $.01 | 457669307 |
| JAZZ | Jazz Pharmaceuticals PLC | 900,000 | $100M | 7.6% | $120.26 | -8.9% | SHS USD | G50871105 |
| CYTK | Cytokinetics Inc | 1,500,000 | $79.2M | 6.0% | $76.39 | -27.0% | COM NEW | 23282W605 |
| — | Inari Medical Inc | 1,550,000 | $63.92M | 4.8% | $42.76 | — | COM | 45332Y109 |
| ACLX | Arcellx Inc | 675,000 | $56.37M | 4.3% | $54.07 | +23.1% | COMMON STOCK | 03940C100 |
| GPCR | Structure Therapeutics Inc | 1,150,000 | $50.47M | 3.8% | $41.64 | — | SPONSORED ADS | 86366E106 |
| KALV | KalVista Pharmaceuticals Inc | 4,000,000 | $46.32M | 3.5% | $12.33 | +2.0% | COM | 483497103 |
| — | Astria Therapeutics Inc | 4,000,000 | $44.04M | 3.3% | $10.83 | — | COM | 04635X102 |
| IMTX | Immatics NV | 3,750,000 | $42.79M | 3.2% | $10.76 | +10.0% | SHS | N44445109 |
| RARE | Ultragenyx Pharmaceutical Inc | 750,000 | $41.66M | 3.2% | $42.97 | +18.5% | COM | 90400D108 |
| ASND | Ascendis Pharma A/S | 250,000 | $37.33M | 2.8% | $129.08 | — | SPONSORED ADR | 04351P101 |
| SLNO | Soleno Therapeutics Inc | 720,000 | $36.35M | 2.8% | $28.45 | +68.3% | COM | 834203309 |
| DAWN | Day One Biopharmaceuticals Inc | 2,500,000 | $34.83M | 2.6% | $14.45 | -1.3% | COM | 23954D109 |
| SVRA | Savara Inc | 8,090,000 | $34.3M | 2.6% | $4.44 | -0.6% | COM | 805111101 |
| AGIO | Agios Pharmaceuticals Inc | 760,000 | $33.77M | 2.6% | $45.42 | 0.0% | COM | 00847X104 |
| XENE | Xenon Pharmaceuticals Inc | 825,000 | $32.48M | 2.5% | $40.76 | -1.1% | COM | 98420N105 |
| BMRN | BioMarin Pharmaceutical Inc | 400,000 | $28.12M | 2.1% | $83.59 | 0.0% | COM | 09061G101 |
| — | Avadel Pharmaceuticals PLC | 2,000,000 | $26.23M | 2.0% | — | — | Put | G29687103 |
| BHVN | Biohaven Ltd | 500,000 | $24.98M | 1.9% | — | — | Call | G1110E107 |
| QURE | uniQure NV | 4,750,000 | $23.42M | 1.8% | $6.46 | +0.8% | SHS | N90064101 |
| JANX | Janux Therapeutics Inc | 485,000 | $22.03M | 1.7% | $46.95 | -7.3% | COM | 47103J105 |
| BDTX | Black Diamond Therapeutics Inc | 5,028,500 | $21.87M | 1.7% | $5.41 | +0.6% | COM | 09203E105 |
| SLDB | Solid Biosciences Inc | 2,800,000 | $19.52M | 1.5% | $8.99 | -9.8% | COM NEW | 83422E204 |
| EW | Edwards Lifesciences Corp | 275,000 | $18.15M | 1.4% | $72.66 | 0.0% | COM | 28176E108 |
| GILD | Gilead Sciences Inc | 200,000 | $16.77M | 1.3% | $73.07 | 0.0% | COM | 375558103 |
| LQDA | Liquidia Corp | 1,500,000 | $15M | 1.1% | $10.47 | +4.3% | COM NEW | 53635D202 |
| A | Agilent Technologies Inc | 100,000 | $14.85M | 1.1% | $135.59 | 0.0% | COM | 00846U101 |
| BMY | Bristol-Myers Squibb Co | 250,000 | $12.94M | 1.0% | $41.01 | +6.4% | COM | 110122108 |
| GSK | GSK PLC | 300,000 | $12.26M | 0.9% | $40.88 | — | SPONSORED ADR | 37733W204 |
| BCAX | Bicara Therapeutics Inc | 425,000 | $10.82M | 0.8% | $25.50 | 0.0% | COM | 055477103 |
| DNTH | Dianthus Therapeutics Inc | 395,000 | $10.82M | 0.8% | $19.89 | +40.1% | COM | 252828108 |
| CRNX | Crinetics Pharmaceuticals Inc | 205,000 | $10.48M | 0.8% | $51.57 | 0.0% | COM | 22663K107 |
| — | iTeos Therapeutics Inc | 1,025,000 | $10.47M | 0.8% | $14.84 | — | COM | 46565G104 |
| — | Applied Therapeutics Inc | 1,145,000 | $9.732M | 0.7% | $4.03 | — | COM | 03828A101 |
| NRIX | Nurix Therapeutics Inc | 425,000 | $9.55M | 0.7% | $15.57 | +45.5% | COM | 67080M103 |
| SNY | Sanofi SA | 150,000 | $8.645M | 0.7% | $57.63 | — | SPONSORED ADR | 80105N105 |
| BRKR | Bruker Corp | 125,000 | $8.633M | 0.7% | $64.19 | 0.0% | COM | 116794108 |
| APGE | Apogee Therapeutics Inc | 136,500 | $8.018M | 0.6% | $47.91 | 0.0% | COM | 03770N101 |
| ZYME | Zymeworks Inc | 615,000 | $7.718M | 0.6% | $9.47 | +15.0% | COM | 98985Y108 |
| LXEO | Lexeo Therapeutics Inc | 850,000 | $7.684M | 0.6% | $14.72 | -19.0% | COM | 52886X107 |
| TARS | Tarsus Pharmaceuticals Inc | 230,000 | $7.565M | 0.6% | $28.11 | 0.0% | COM | 87650L103 |
| ANRO | Alto Neuroscience Inc | 650,000 | $7.436M | 0.6% | $13.99 | -12.5% | COM SHS | 02157Q109 |
| BDX | Becton Dickinson & Co | 30,000 | $7.233M | 0.5% | $227.63 | 0.0% | COM | 075887109 |
| MDGL | Madrigal Pharmaceuticals Inc | 30,000 | $6.367M | 0.5% | $255.83 | 0.0% | COM | 558868105 |
| LEGN | Legend Biotech Corp | 125,000 | $6.091M | 0.5% | $48.73 | — | SPONSORED ADS | 52490G102 |
| FATE | Fate Therapeutics Inc | 1,685,000 | $5.897M | 0.4% | $3.57 | +9.0% | COM | 31189P102 |
| GLPG | Galapagos NV | 180,000 | $5.182M | 0.4% | $36.24 | — | SPON ADR | 36315X101 |
| URGN | UroGen Pharma Ltd | 400,000 | $5.08M | 0.4% | $14.84 | 0.0% | COM | M96088105 |
| GLUE | Monte Rosa Therapeutics Inc | 930,000 | $4.929M | 0.4% | $5.10 | -1.0% | COM | 61225M102 |
| GERN | Geron Corp | 1,050,000 | $4.767M | 0.4% | $4.55 | 0.0% | COM | 374163103 |
| — | Passage Bio Inc | 6,100,000 | $4.27M | 0.3% | $1.21 | — | COM | 702712100 |
| ALLO | Allogene Therapeutics Inc | 1,500,000 | $4.2M | 0.3% | $3.70 | -28.0% | COM | 019770106 |
| PRME | Prime Medicine Inc | 1,070,000 | $4.141M | 0.3% | $5.75 | -19.4% | COM | 74168J101 |
| VTYX | Ventyx Biosciences Inc | 1,725,000 | $3.76M | 0.3% | $3.71 | -38.1% | COM | 92332V107 |
| ZVRA | Zevra Therapeutics Inc | 525,000 | $3.643M | 0.3% | $6.78 | 0.0% | COM NEW | 488445206 |
| ARDX | Ardelyx Inc | 500,000 | $3.445M | 0.3% | $5.90 | 0.0% | COM | 039697107 |
| PTCT | PTC Therapeutics Inc | 80,000 | $2.968M | 0.2% | $32.39 | +3.3% | COM | 69366J200 |
| PEN | Penumbra Inc | 15,000 | $2.915M | 0.2% | $188.96 | 0.0% | COM | 70975L107 |
| VYGR | Voyager Therapeutics Inc | 490,000 | $2.866M | 0.2% | $9.31 | — | COM | 92915B106 |
| MGNX | MacroGenics Inc | 830,000 | $2.731M | 0.2% | $14.22 | -72.6% | COM | 556099109 |
| — | Verve Therapeutics Inc | 525,000 | $2.541M | 0.2% | $4.88 | — | COM | 92539P101 |
| — | Intra-Cellular Therapies Inc | 30,000 | $2.195M | 0.2% | $73.17 | — | COM | 46116X101 |
| ESTA | Establishment Labs Holdings In | 40,000 | $1.731M | 0.1% | $43.48 | 0.0% | COM | G31249108 |
| RLMD | Relmada Therapeutics Inc | 490,000 | $1.588M | 0.1% | $4.64 | -30.2% | COM | 75955J402 |
| — | Achilles Therapeutics PLC | 1,500,000 | $1.53M | 0.1% | $1.22 | — | SPONSORED ADS | 00449L102 |
| — | Reneo Pharmaceuticals Inc | 799,400 | $1.359M | 0.1% | $1.60 | — | COM | 75974E103 |
| — | Chimerix Inc | 1,400,000 | $1.302M | 0.1% | $0.96 | — | COM | 16934W106 |
| ATRA | Atara Biotherapeutics Inc | 124,677 | $1.014M | 0.1% | $14.38 | -40.4% | COM NEW | 046513206 |
| TENX | Tenax Therapeutics Inc | 83,333 | $288K | 0.0% | $3.62 | 0.0% | COM NEW | 88032L605 |